BUCHARDT DORTE has a total of 15 patent applications. Its first patent ever was published in 1992. It filed its patents most often in EPO (European Patent Office), Japan and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are BUCHARDT OLE, INFECTIO DIAGNOSTIC INC and CHANT JOHN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Japan | 5 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | Czechia | 1 | |
#6 | Hungary | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Peptides | |
#3 | Sugars | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Microorganisms | |
#7 | Nanostructure applications | |
#8 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Egholm Michael | 15 |
#2 | Buchardt Ole | 13 |
#3 | Nielsen Peter Eigil | 10 |
#4 | Berg Rolf Henrik | 9 |
#5 | Stanley Christopher John | 4 |
#6 | Nielsen Peter E | 4 |
#7 | Berg Rolf H | 3 |
#8 | Berg Rolf Hendrik | 1 |
#9 | Buchardt Ole Di | 1 |
#10 | Buchardt M Dorte | 1 |
Publication | Filing date | Title |
---|---|---|
CA2261566A1 | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |